combination therapy Archives

Synergy for Staphylococcus Skin and Skin Structure Infection

Staphylococcus aureus, particularly methicillin-resistant Staphylococcus aureus (MRSA), is a leading cause of skin and skin structure infections (SSSIs), encompassing cellulitis, abscesses, wound infections, and impetigo.…

synergy for p. aeruginosa infection in cystic fibrosis

Diseases S

Synergistic Therapeutic Strategies for Pseudomonas aeruginosa

Cystic fibrosis (CF) is a genetic disorder characterized by defective chloride ion transport, leading to thickened mucus in the airways. This viscous environment predisposes patients…

synergy for nosocomial pneumonia due to pseudomonas aeruginosa

Diseases S

Synergistic Antibiotic Strategies for Nosocomial Pneumonia

Nosocomial pneumonia, particularly ventilator-associated pneumonia (VAP), remains one of the most prevalent and severe hospital-acquired infections. Pseudomonas aeruginosa, a non-fermenting Gram-negative bacillus, ranks among the…